North America Urinalysis Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2035)
North America Urinalysis Market: by Type (Consumables, Instruments), Application (Disease Screening, Pregnancy and Fertility Testing, Drug Testing, Others), Distribution Channels (Hospital Laboratories, Independent Laboratories, Physician Offices, Clinics, Research Institutes, Others), Technology (Biochemical Urinalysis, Microscopic Urinalysis, Flow Cytometry, Chromatography, Others), Organization Size (Small, Medium, Large) and By North America Historical & Forecast Period (2020-2035) Comprehensive Study 2025
Last Updated: 31-07-2025 | Format: PDF | Report ID:20270 | Author: Clara
The North America urinalysis market is witnessing robust growth, propelled by rising incidences of chronic diseases, an aging population, and advancements in diagnostic technologies. Urinalysis, a critical tool for disease screening and health monitoring, encompasses consumables and instruments deployed across diverse healthcare settings. The market is segmented by type, application, technology, distribution channel, and organization size, with growing adoption in hospital laboratories, independent labs, and physician offices. Innovations such as automation, biochemical, and molecular urinalysis have further transformed testing efficiency, accuracy, and turnaround times. Continual product launches and expansion strategies by leading players, coupled with increasing healthcare expenditure and preventive care awareness, are setting the stage for steady expansion through 2035.
Latest Market Dynamics
Key Drivers
Rising prevalence of chronic diseases such as diabetes and kidney disorders is driving the demand for urinalysis testing across North America. For example,
has introduced advanced urinalysis analyzers to support the early detection of renal diseases and diabetes complications as part of its preventive care initiatives.
Technological advancements such as automation in urinalysis and integration with laboratory information systems are improving test throughput and accuracy. Siemens Healthineers recently expanded its Atellica series with AI-powered urinalysis modules to streamline workflow and reduce manual errors.
Key Trends
The adoption of point-of-care urinalysis devices is increasing, enabling rapid results and improving clinical decision making in both hospital and primary care settings. Becton, Dickinson and Company expanded its point-of-care diagnostics portfolio in early 2025 to offer real-time urinalysis testing in physician offices.
Integration of urinalysis testing with digital health platforms and electronic medical records is accelerating, supporting better patient management and data-driven insights. Roche Diagnostics launched cloud-linked urinalysis analyzers designed for seamless EMR integration in North America.
Key Opportunities
Expanding the application of urinalysis tests for early detection and monitoring of urinary tract infections, kidney diseases, and diabetes offers significant growth potential. Thermo Fisher Scientific is investing in research to develop multiplexed urinalysis kits for broader screening capabilities.
Growing demand from independent laboratories and clinics, driven by preference for rapid, high-throughput, and cost-effective testing solutions. ARKRAY USA, Inc. is addressing these market needs with affordable and scalable urinalysis analyzers.
Key Challenges
Data management and integration challenges when scaling automated urinalysis systems across large health networks. Sysmex Corporation is working on standardizing data protocols for interoperability, but variability remains a key challenge.
Ensuring consistent accuracy and reliability of rapid urinalysis devices, particularly for point-of-care testing and self-monitoring. Bio-Rad Laboratories continues to invest in enhanced QC processes to address concerns around variability in test results.
Key Restraints
High initial investment and maintenance costs of advanced urinalysis equipment act as a barrier to adoption in small and medium institutions. Smaller clinics often hesitate to upgrade due to budget considerations despite proven benefits, as noted in recent Mindray Medical reports.
Regulatory compliance and reimbursement hurdles for novel test types or automation solutions, slowing speed to market. Recent updates to FDA regulations affected introduction timelines for new urinalysis solutions from QuidelOrtho Corporation.
North America Urinalysis Market Share by Type, 2025
Consumables account for the largest share in the North America urinalysis market in 2025, driven by their recurring demand and critical role in routine testing. Instruments, including automated analyzers, represent a substantial segment as healthcare providers seek efficiency and accuracy. Increased focus on disease prevention and point-of-care diagnostics continues to bolster both consumables and instrument sales. While test kits and disposables maintain steady adoption, innovation in reagent formulations and digital dipsticks underscore the evolving nature of the market. The competitive landscape is shaped by continual product launches targeting workflow optimization and cost efficiency enhancements. As technological advancements persist, the mix between consumables and instruments is expected to shift, further propelling market growth.
North America Urinalysis Market Share by Applications, 2025
Disease screening leads the application segment in the North America urinalysis market, reflecting the high prioritization of early detection protocols in healthcare systems. Pregnancy and fertility testing maintains significant demand due to ongoing advancements in reproductive health diagnostics. Drug testing remains a key segment, spurred by regulatory mandates and workplace health programs. The market also benefits from continued adoption in diabetes screening, kidney disease diagnostics, and UTI detection. This diverse application base, coupled with the proliferation of both clinical and point-of-care urinalysis, supports the upward revenue trajectory of the sector. Companies are developing multiplexed and integrated testing solutions to broaden clinical utility and operational efficiency.
North America Urinalysis Market Revenue (USD Million), 2020-2035
The North America urinalysis market is projected to grow from $1,650 million in 2020 to $3,450 million by 2035, at a CAGR of 6.2%. Consistent growth is attributed to the rising burden of chronic diseases, persistent technological advancements, and expanding adoption in both clinical and point-of-care settings. The period between 2025 and 2030 anticipates the fastest revenue acceleration, coinciding with widespread laboratory automation and broader reimbursement coverage for advanced diagnostic solutions. As healthcare infrastructure continues to modernize, demand for efficient and high-throughput urinalysis platforms will drive further market expansion.
North America Urinalysis Market YOY Growth (%), 2020-2035
Year-over-year growth in the North America urinalysis market remains robust, averaging 6.2% from 2020 to 2030 before moderating slightly towards 2035 as the market matures. The most significant YOY jumps occur post-2025, with a surge resulting from increased adoption of automation and digital urinalysis technologies. Despite occasional slowdowns attributable to regulatory adjustments, sustained investments in disease screening initiatives and the launch of next-generation urinalysis devices ensure stable expansion.
North America Urinalysis Market Share by Region, 2025
The United States commands the dominant share of the North America urinalysis market in 2025, accounting for 78% of revenue. This leadership is propelled by robust healthcare infrastructure, high prevalence of target diseases, and rapid uptake of innovative diagnostic solutions. Canada follows with a 15% share, reflecting increased preventive health initiatives and technology investments, while Mexico contributes 7%, underpinned by rising awareness and improving healthcare access. Growth is expected to continue across all regions, with cross-border collaboration and regional investment driving incremental gains.
North America Urinalysis Market Players Share (%), 2025
The competitive landscape in the North America urinalysis market is slightly fragmented with leading players holding a majority share. Siemens Healthineers, Abbott Laboratories, and Roche Diagnostics collectively account for 49% of the market in 2025, reflecting extensive portfolios and strong innovation pipelines. The remainder is distributed among established names like Sysmex Corporation, Becton, Dickinson and Company, and other specialized providers. This structure is maintained by continual product launches, strategic collaborations, and investments in laboratory automation and digital integration.
North America Urinalysis Market Buyers Share (%), 2025
Hospital laboratories remain the principal buyers in the North America urinalysis market, holding 56% of share in 2025 due to their high test volumes and demand for sophisticated automation. Independent laboratories, representing 24%, increasingly adopt rapid and multiplexed solutions to serve broader client bases. Physician offices and clinics account for 15%, driven by the growing trend toward near-patient and point-of-care diagnostics. Research institutes and others comprise the balance, leveraging advanced urinalysis for ongoing studies and clinical trials.
Study Coverage
Metrics
Details
Years
2020-2035
Base Year
2025
Market Size
2200
Regions
United States, Canada, Mexico
Segments
By Type, By Application, By Technology, By Distribution Channels, By Organization Size
July 2024: Siemens Healthineers introduced a next-generation automated urinalysis analyzer with AI-powered result interpretation for North American labs.
August 2024: Abbott Laboratories announced FDA clearance for its latest digital urinalysis dipstick integrated with cloud-based reporting.
September 2024: Roche Diagnostics launched a portable urinalysis platform designed for remote and decentralized clinical settings in the US and Canada.
June 2024: Becton, Dickinson and Company expanded its point-of-care urinalysis solutions portfolio targeting clinics and physician offices.
October 2024: Sysmex Corporation collaborated with major hospital networks to pilot interoperable urinalysis data solutions across North America.
Frequently Asked Questions
About the Author
Clara
Senior Market Research Analyst
Clara is a Senior Market Research Analyst specializing in market research, industry analysis, and business consulting across Healthcare. Clara brings a commercially grounded perspective to sectors shaped by changing demand, innovation, and competitive dynamics, helping turn complex market trends into clear strategic insights for business decision-makers. With 10+ years of experience across research, analytics, and strategic advisory roles, Clara has helped organizations translate data into actionable growth strategies.
